Ischemic Postconditioning in Carotid Surgery
Conditions: Ischemic Postconditioning; Carotid Surgery; Stroke; Carotid Artery Diseases Interventions: Procedure: Ischemic postconditioning in carotid surgery; Procedure: Eversion Carotid Endarterectomy Sponsors: Institute for Cardiovascular Diseases " Dedinje " Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials

Effect of Caffeine Consumption on Protein Biomarkers and Cardiovascular Disease
Conditions: Healthy Interventions: Drug: Caffeine Pill; Drug: Placebo; Device: TASSO+ Device; Device: Finger prick and collection on Whatman Protein 903 Saver Cards; Device: Intravenous Sampling Sponsors: Hamilton Health Sciences Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials

Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
Conditions: Mortality; Surgical Complication; Neurological Complication; Respiratory Complication; Cardiovascular Complication; Nephrotoxicity; Metabolic Complication Sponsors: Asst Melegnano e Martesana Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials

mHealth Rhythm Management in Terms of Cancelling Unnecessary Scheduled ECVs in Presumed Persistent AFpatients.
Conditions: Atrial Fibrillation; Arrhythmia; Mobile Health; Electrical Cardioversion Sponsors: Maastricht University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials

Knowledge, Attitudes and Practices of Paediatric Cardiologists About Cardiac Rehabilitation in Children With Congenital Heart Disease
Conditions: Physician ' s Role Interventions: Other: Questionnaire on knowledge, attitudes and practices of paediatric cardiologists about cardiac rehabilitation in children with congenital heart disease Sponsors: Karamano ğlu Mehmetbey University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Simulator Training to Improve Interventional Cardiologist Skills (STARTERS) Trial
Conditions: Coronary Artery Disease Interventions: Procedure: Simulator-based training; Procedure: Standard training Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Sapphire 3 CTO Study
Conditions: Coronary Artery Disease; Coronary Disease; Myocardial Ischemia; Heart Diseases; Arteriosclerosis; Cardiovascular Diseases; Chronic Total Occlusion; Chronic Total Occlusion of Coronary Artery Interventions: Device: Sapphire 3 Coronary Dilatation Catheter Sponsors: OrbusNeich; Avania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Conditions: Heart Failure; Left Ventricular Dysfunction; Idiopathic Dilated Cardiomyopathy Interventions: Diagnostic Test: Thermodilution based assessment of coronary microcirculation Sponsors: Azienda Ospedaliera Universitaria Integrata Verona; Abbott Medical Devices Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

A Study to Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.
Conditions: Arrhythmias, Cardiac; Atrial Fibrillation; Heart Diseases Interventions: Device: TS-RF Transseptal Needle; Device: BRK Transseptal Needle Sponsors: Starmed; Helptrial Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Cardiovascular Disease Risk in Children With Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes Interventions: Device: Echocardiography Sponsors: Ankara City Hospital Bilkent Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Re-infusion of Unwashed Shed Blood During Off-pump Surgery
Conditions: Coronary Artery Disease; Blood Transfusion Complication; Cardiovascular Complication Interventions: Procedure: Re-infusion of unwashed shed blood Sponsors: Damascus University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes
Conditions: Coronary Artery Disease; Cancer Sponsors: Samsung Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

A Prospective, Multi-center, Randomized, Single-blind, Non-inferiority Confirmatory Study Designed to Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.
Conditions: Arrhythmias, Cardiac; Atrial Fibrillation; Heart Diseases Interventions: Device: TS-RF Transseptal Needle; Device: BRK Transseptal Needle Sponsors: Starmed; Helptrial Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access.
Conditions: Arrhythmias, Cardiac; Atrial Fibrillation; Heart Diseases Interventions: Device: TS-RF Transseptal Needle; Device: BRK Transseptal Needle Sponsors: Starmed; Helptrial Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
PONTE VEDRA, Fla., April 9, 2024— Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 9, 2024 Category: Pharmaceuticals Source Type: clinical trials